Potential Increasing Trend in Schizophrenia Relapse Prevention in the Past 40 Years: A Bibliometric Analysis

  • 0Department of Public Health, Doctoral Student Public Health Faculty, Hasanuddin University, Makassar, Indonesia.

Summary

This summary is machine-generated.

Research on schizophrenia relapse prevention is growing, with the United States leading publications. This study analyzes trends and influential work in schizophrenia relapse prevention strategies.

Area Of Science

  • Psychiatry and Mental Health
  • Bibliometrics
  • Public Health

Background

  • Schizophrenia is a severe mental disorder with a high relapse rate, prompting research into effective prevention strategies.
  • The increasing incidence of schizophrenia relapse necessitates innovative interventions and a comprehensive understanding of research trends.
  • Bibliometric analysis provides insights into the evolution and impact of research in specific scientific fields.

Purpose Of The Study

  • To analyze publication trends in schizophrenia relapse prevention from 1973 to 2023.
  • To assess international collaboration patterns and identify key contributors in the field.
  • To determine influential authors, articles, and keywords, and to forecast future research directions in schizophrenia relapse prevention.

Main Methods

  • A comprehensive bibliometric analysis of 683 articles sourced from the Scopus database.
  • Data analysis utilizing VOSviewer software for network visualization and trend identification.
  • Visualization of findings using Tableau for enhanced interpretability.

Main Results

  • A significant increase in publications on schizophrenia relapse prevention over the last three decades, indicating sustained research interest.
  • The United States emerged as the leading contributor in terms of publication volume.
  • John M. Kane identified as the most prolific author, and Stefan Leucht as having the highest h-index. Keywords like "relapse AND schizophrenia" AND "prevention" are frequently used.

Conclusions

  • The findings offer a valuable reference for understanding the current landscape of schizophrenia relapse prevention research.
  • This bibliometric analysis highlights key trends, influential contributors, and areas for future investigation in schizophrenia relapse prevention.
  • The study provides a foundation for strategic planning and resource allocation in advancing schizophrenia relapse prevention efforts.

Related Concept Videos

Psychological and Sociocultural Causes of Schizophrenia 01:29

81

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

Biological Causes of Schizophrenia 01:29

51

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

Regression Toward the Mean 01:52

6.3K

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders 01:27

520

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...

Psychosis and Antipsychotic Drugs: Overview 01:28

203

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...

Psychosis: Goals of Pharmacotherapy 01:26

113

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.